<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Patricia Tai, MB, BS, DMRT, FRCR, FRCPC
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul T Nghiem, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Song Youn Park, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert S Stern, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            June K Robinson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sonali M Shah, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 23, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2143457282">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Merkel cell carcinoma (MCC) is a rare, aggressive, cutaneous malignancy that predominantly affects older adults with light skin types and has a high propensity for recurrence and metastases [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The pathogenesis, clinical features, and diagnosis of MCC are discussed here. The staging, treatment, and surveillance of patients with locoregional MCC and the treatment of recurrent and metastatic MCC are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7609.html" rel="external">
          "Staging, treatment, and surveillance of locoregional Merkel cell carcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139691.html" rel="external">
          "Treatment of recurrent and metastatic Merkel cell carcinoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H59398509">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple studies report increasing incidence of Merkel cell carcinoma (MCC) in several countries over the past decades [
         <a href="#rid2">
          2-9
         </a>
         ]. Data from the Surveillance, Epidemiology, and End Results (SEER) Program database indicate that in the United States, the estimated annual incidence rate rose from 0.5 cases per 100,000 persons in 2000 (95% CI 0.4-0.5) to 0.7 cases per 100,000 persons in 2013 (95% CI 0.7-0.8). MCC incidence increases exponentially with advancing age, from 0.1 to 1 to 9.8 (per 100,000 person-years) among age groups 40 to 44, 60 to 64, and &gt;85 years, respectively. Due to aging of the population, the United States' MCC incidence is predicted to climb to more than 3200 cases in 2025 [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H59398515">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recognized risk factors for MCC include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Light skin color
         </strong>
         – MCC predominantly affects persons with light skin [
         <a href="#rid10">
          10,11
         </a>
         ]. A study analyzing SEER data from 1973 to 2006 found that 95 percent of cases diagnosed during this interval arose in White individuals [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increasing age
         </strong>
         – MCC is typically seen in older individuals, with a mean age at diagnosis of 74 to 76 years [
         <a href="#rid10">
          10,11
         </a>
         ]. MCC incidence increases in advanced age groups, with an almost 10-fold increase every 20 years of increasing age [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Male sex
         </strong>
         – In general, the incidence of MCC is higher in males than in females. In an analysis of United States cancer registries including the National Program of Cancer Registries, the reported incidence rate was 4.2 per 100,000 persons for males and 1.9 per 100,000 persons for females, and the male-to-female ratio was 2.2 (95% CI 2.1-2.4) [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunosuppression
         </strong>
         – The incidence of MCC is more frequent in immunosuppressed patients, such as organ transplant recipients [
         <a href="#rid12">
          12-17
         </a>
         ], individuals infected with human immunodeficiency virus (HIV) [
         <a href="#rid18">
          18,19
         </a>
         ], and those with hematologic malignancies [
         <a href="#rid11">
          11,12,20
         </a>
         ]. MCC occurs at a younger age and higher incidence in immunosuppressed individuals [
         <a href="#rid11">
          11-14,18-20
         </a>
         ]. Data from the United States Scientific Registry of Transplant Recipients and 15 population-based cancer registries indicate that transplant recipients have a 24-fold higher risk of MCC than immunocompetent patients [
         <a href="#rid12">
          12
         </a>
         ]. The highest incidence occurs 10 or more years after transplant. Maintenance treatment with mammalian (mechanistic) target of rapamycin (mTOR) inhibitors and
         <a class="drug drug_general" data-topicid="9026" href="/z/d/drug information/9026.html" rel="external">
          azathioprine
         </a>
         or
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         confers a higher risk of MCC [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="local">
          'Immunosuppression'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         <strong>
          malignancies
         </strong>
         – The risk of MCC is significantly increased in patients with other malignancies, especially hematologic malignancies [
         <a href="#rid20">
          20,21
         </a>
         ]. In a SEER database study of over two million patients with cancer, the risk of MCC was significantly increased in those with multiple myeloma, chronic lymphocytic leukemia, and malignant melanoma (standardized incidence ratio [SIR] 3.7, 6.9, and 3.1, respectively) [
         <a href="#rid20">
          20
         </a>
         ]. Increased incidence of MCC in patients with hematologic malignancies is likely due to immunosuppression and immune dysregulation associated with those conditions [
         <a href="#rid14">
          14
         </a>
         ]. A retrospective study of 4164 patients with chronic lymphocytic leukemia and 172 patients with MCC supported the association between these two disorders reported in the SEER database study [
         <a href="#rid22">
          22
         </a>
         ]. Among patients with a diagnosis of chronic lymphocytic leukemia, the incidence of a subsequent diagnosis of MCC was greatly elevated (SIR 15.7, 95% CI 3.2-46). Patients with a preceding diagnosis of MCC also exhibited an increased risk for developing chronic lymphocytic leukemia (SIR 17.9, 95% CI 2.2-64.6).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2404710462">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several factors have been associated with the development of Merkel cell carcinoma (MCC). These include infection with the Merkel cell polyomavirus (MCPyV), ultraviolet (UV) radiation exposure, and immunosuppression. (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1807269141">
         <span class="h2">
          Cell of origin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based upon early histologic and ultrastructural studies, MCC has traditionally been believed to arise from Merkel cells, which are located in the basal layer of the epidermis and hair follicles and are associated with sensory neurites in the dermal papillae, the skin mechanoreceptors [
         <a href="#rid23">
          23
         </a>
         ]. However, this hypothesis is controversial. An alternative hypothesis is that these tumors originate from an immature multipotent stem cell that acquires neuroendocrine features during malignant transformation [
         <a href="#rid24">
          24
         </a>
         ]. Based on cancer genomic studies and an understanding of the two different etiologies of MCC (MCPyV-positive or MCPyV-negative MCCs), it is plausible that MCC tumors might not have a single cell of origin. MCPyV-positive MCCs might arise from dermal fibroblasts and MCPyV-negative MCCs from epidermal keratinocytes, but this is a highly controversial area [
         <a href="#rid25">
          25,26
         </a>
         ]. In contrast, data clearly suggest that MCPyV-negative MCC tumors likely arise from keratinocytes [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="local">
          'Merkel cell polyomavirus'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Merkel cell polyomavirus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Merkel cell polyomavirus (MCPyV) is a nonenveloped, double-stranded DNA virus that has been causally linked to the development of MCC  (
         <a class="graphic graphic_picture graphicRef61586" href="/z/d/graphic/61586.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid28">
          28-31
         </a>
         ]. Previous studies have consistently reported that MCPyV can be detected in approximately 80 and 60 percent of all MCCs by real-time polymerase chain reaction (PCR) and immunohistochemistry, respectively [
         <a href="#rid32">
          32
         </a>
         ]. A 2015 meta-analysis of 23 studies found an overall MCPyV prevalence of 79 percent (95% CI 72-84 percent) in Merkel cell tumors versus 12 percent (95% CI 8-9 percent) in control skin samples [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         MCPyV is a ubiquitous virus, with five specific geographically related genotypic variants [
         <a href="#rid34">
          34
         </a>
         ]. MCPyV is thought to be part of the human skin microbiome and appears to be chronically shed from the skin in the form of assembled virions [
         <a href="#rid35">
          35
         </a>
         ]. The seroprevalence of antibodies specific to the capsid viral protein 1 (VP1) appears to increase with age, from approximately 40 percent in children to up to over 80 percent in older individuals [
         <a href="#rid31">
          31,36-38
         </a>
         ].
        </p>
        <p>
         The observation that the integration of the virus into the tumor genome precedes the clonal expansion of tumor cells suggests that the virus is present at tumor initiation and that one or more viral proteins are oncogenic drivers [
         <a href="#rid28">
          28,39
         </a>
         ]. MCPyV encodes two main oncoproteins, the large tumor (LT) antigen and small tumor (sT) antigen, which are both persistently expressed in MCC and have been implicated in oncogenesis through multiple mechanisms. Sequential events involved in the pathogenesis of MCPyV-positive tumors include clonal integration into the host genome, expression of sT, acquisition of mutations in the 3' end of LT, and evasion of a destructive immune response [
         <a href="#rid1">
          1,40,41
         </a>
         ].
        </p>
        <p>
         Mutations in LT result in a truncated molecule that lacks the DNA binding domain and the helicase domain, which renders the virus replication incompetent while preserving its retinoblastoma (
         <em>
          RB1
         </em>
         ) gene binding property and the expression of the oncogenic viral proteins [
         <a href="#rid42">
          42
         </a>
         ]. LT antigens with intact
         <em>
          RB1
         </em>
         binding domain sequester and inactivate the tumor suppressor, resulting in sustained tumor growth.
        </p>
        <p>
         MCPyV has been detected in normal-appearing skin and in other tumors, including cutaneous squamous cell carcinoma, chronic lymphocytic leukemia, and folliculotropic mycosis fungoides [
         <a href="#rid43">
          43-49
         </a>
         ]. In one series of patients with MCC, skin samples taken from sites distant from the tumor were positive for the virus in 10 out of 14 cases (71 percent), a frequency higher than that was observed in six skin samples from unaffected individuals (17 percent) [
         <a href="#rid43">
          43
         </a>
         ]. Importantly, outside of MCC, evidence of clonal integration of the virus and expression of viral proteins in tumor cells is almost invariably lacking in other cancers, suggesting that the occasional detection of the virus was likely coincidental rather than causal in non-MCC tumors [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H59398060">
         <span class="h2">
          Ultraviolet radiation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ultraviolet (UV) radiation exposure, especially to the sun, is thought to play an important role in the etiology of many cases of MCC. The following observations are consistent with an etiologic role for UV radiation exposure:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         MCC has a predilection for sun-exposed areas. In a study of the clinical manifestations in 195 cases of MCC, the tumor arose in a UV-exposed region in 81 percent of assessable cases [
         <a href="#rid11">
          11
         </a>
         ]. Furthermore, 98 percent of cases occurred in individuals with lightly pigmented skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Regional incidence rates correlate with increasing sun exposure, as measured by the ultraviolet B (UVB) solar index [
         <a href="#rid7">
          7,8,51,52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presentation with other skin cancers, for which sun exposure is a major risk factor, is common [
         <a href="#rid21">
          21,53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">
          "Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5337.html" rel="external">
          "Cutaneous squamous cell carcinoma: Epidemiology and risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         MCC has been described in patients treated with psoralen plus ultraviolet A (PUVA) photochemotherapy [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple reports describe UVB signature mutations in MCC tumors [
         <a href="#rid55">
          55-58
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         UV radiation exposure may be especially relevant in the pathogenesis of the virus-negative subtype of MCC (see
         <a class="local">
          'Virus-negative Merkel cell carcinoma'
         </a>
         below). This hypothesis is supported by the observation that in Australia the incidence of MCC is highest, but the prevalence of MCPyV-positive tumors is much lower than in other geographic areas. An Australian study of 95 MCC reported a 23 percent prevalence of MCPyV positivity; the prevalence was even lower in tumors occurring in skin areas with evidence of sun damage (ie, elastosis, squamous dysplasia) [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Immunosuppression
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of MCC is increased in immunosuppressed patients, including organ transplant recipients [
         <a href="#rid12">
          12-17
         </a>
         ], individuals infected with HIV [
         <a href="#rid18">
          18,19
         </a>
         ], and those with hematologic malignancies [
         <a href="#rid11">
          11,12,20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16332.html" rel="external">
          "Epidemiology and risk factors for skin cancer in solid organ transplant recipients", section on 'Merkel cell carcinoma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8036.html" rel="external">
          "HIV infection and malignancy: Management considerations", section on 'Merkel cell carcinoma'
         </a>
         .)
        </p>
        <p>
         The mechanism by which immunosuppression interacts with MCPyV and UV radiation exposure in the pathogenesis of MCC is unknown. Immunosuppression may facilitate the replication of MCPyV and increase the chance of virus integration in the MCC progenitor cell. In addition, reduced immune surveillance may contribute to the survival and proliferation of atypical cells. Finally, immunosuppressive agents, such as
         <a class="drug drug_general" data-topicid="9026" href="/z/d/drug information/9026.html" rel="external">
          azathioprine
         </a>
         or calcineurin inhibitors, have been shown to act synergistically with UV radiation in inducing mutagenesis and promoting skin carcinogenesis in an immunosuppression-independent manner [
         <a href="#rid60">
          60-64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H65922917">
         <span class="h2">
          Virus-negative Merkel cell carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some MCCs have low or negligible levels of MCPyV T antigen expression. The mechanisms of oncogenesis underlying MCPyV-negative MCC are incompletely understood, but they are thought to involve somatic mutations in tumor suppressor genes such as
         <em>
          TP53
         </em>
         and retinoblastoma (
         <em>
          RB1
         </em>
         ), as well as epigenetic alterations, such as DNA methylation and microRNAs, resulting in aberrant expression and activity of oncogenes [
         <a href="#rid42">
          42,65-68
         </a>
         ]. Mutations in
         <em>
          TP53
         </em>
         (encoding p53) occur infrequently in MCCs and have been found almost exclusively in tumors with low or complete lack of MCPyV LT antigen expression [
         <a href="#rid57">
          57,69
         </a>
         ]. The expression of retinoblastoma protein (RB), a key cell cycle regulator, is low or absent in viral-negative tumors, whereas nearly all MCPyV-positive tumors are also RB-positive [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         The frequency of
         <em>
          TP53
         </em>
         mutations, either UV signature mutations or non-UV signature mutations, appears to be higher in MCPyV-negative MCCs than in MCPyV-positive tumors [
         <a href="#rid70">
          70
         </a>
         ]. An analysis of MCPyV-positive and MCPyV-negative MCCs using next-generation sequencing found an overall high mutational burden in MCPyV-negative tumors compared with MCPyV-positive tumors [
         <a href="#rid57">
          57
         </a>
         ]. In MCPyV-negative tumors, the majority of tandem substitutions were CC &gt; TT substitutions, characteristic of UV mutational signature, whereas only one CC &gt; TT tandem substitution was detected across all MCPyV-positive tumors. Activating oncogenic mutations in
         <em>
          HRAS
         </em>
         ,
         <em>
          PIK3CA
         </em>
         ,
         <em>
          KNSTRN
         </em>
         ,
         <em>
          PREX2
         </em>
         , and
         <em>
          RAC1
         </em>
         were found in six of eight MCPyV-negative tumors but only in two of eight MCPyV-positive tumors. Highly recurrent mutations in tumor suppressor genes, including
         <em>
          TP53
         </em>
         ,
         <em>
          RBI
         </em>
         ,
         <em>
          NOTCH1
         </em>
         , and
         <em>
          PRUNE2
         </em>
         , were also found in MCPyV-negative tumors. These findings suggest that genetic aberrations independent of MCPyV infection are involved in the pathogenesis of viral-negative MCCs.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Merkel cell carcinoma (MCC) typically presents in older patients with light skin tones as a rapidly growing, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule  (
         <a class="graphic graphic_picture graphicRef70535 graphicRef50573 graphicRef52988" href="/z/d/graphic/70535.html" rel="external">
          picture 2A-C
         </a>
         ). Ulceration and crusting are relatively infrequent. MCCs range in size from less than 1 cm to over 2 cm and are most often located in sun-exposed areas.
        </p>
        <p>
         In an analysis of 9387 MCC cases from the National Cancer Database between 1998 and 2012 (median age 76 years), the most frequent anatomic locations for the primary tumor were the following [
         <a href="#rid71">
          71
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Head and neck – 43 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Upper limbs and shoulder – 24 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lower limbs and hip – 15 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trunk – 11 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other areas – 9 percent
        </p>
        <p>
        </p>
        <p>
         In this series, patients presented with local disease only in 65 percent of cases, while 26 percent had regional lymph node involvement at presentation, and 8 percent had distant metastases; 3.6 percent had lymph node involvement with an unknown primary tumor and without distant metastases. In these patients, the primary tumor may have spontaneously regressed [
         <a href="#rid72">
          72-75
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Merkel cell carcinoma (MCC) is often clinically misdiagnosed as a benign lesion (eg, cyst, lipoma, pyogenic granuloma) [
         <a href="#rid11">
          11
         </a>
         ]. A high index of suspicion is required if the diagnosis is to be made without delay. An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) registry from 1973 to 2014 on over 3400 patients with MCC found that younger age (&lt;65 years), male sex, and location of the tumor on the trunk or extremities were all associated with late-stage disease at diagnosis [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H68535716">
         <span class="h2">
          Clinical
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lesion features that suggest a biopsy include a rapidly growing, nontender lesion on sun-exposed skin in an older person with lightly pigmented skin, particularly if chronic immune suppression is present. These features can be easily remembered by the acronym AEIOU, derived from a series of 195 cases seen over a period of 27 years [
         <a href="#rid11">
          11
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asymptomatic – 88 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Expanding rapidly (significant growth in ≤3 months) – 63 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immune suppression (HIV infection, solid organ transplant recipient, chronic lymphocytic leukemia) – 8 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older than 50 years age – 90 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ultraviolet (UV)-exposed area in an individual with lightly pigmented skin – 81 percent
        </p>
        <p>
        </p>
        <p>
         The presence of at least three of these features increases the suspicion of MCC. Lesion biopsy and histologic examination are necessary to establish the diagnosis. (See
         <a class="local">
          'Histopathology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3706811795">
         <span class="h2">
          Dermoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data on the dermoscopic findings of MCC are limited, and features specific to a diagnosis of MCC have not been identified. Some of the dermoscopic findings reported in small, retrospective series include milky red areas; linear, irregular vessels; and polymorphous vessels  (
         <a class="graphic graphic_picture graphicRef102595" href="/z/d/graphic/102595.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid77">
          77-80
         </a>
         ]. However, dermoscopy is unlikely to be broadly useful for the clinical diagnosis of MCC due to a lack of specific features, the rarity of MCC, and the need for a highly experienced dermoscopist to potentially recognize features suspicious of MCC. (See
         <a class="medical medical_review" href="/z/d/html/13521.html" rel="external">
          "Overview of dermoscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Histopathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both routine studies with hematoxylin and eosin as well as immunohistochemical stains are usually required to distinguish MCC from other poorly differentiated tumors. MCC typically presents as a dermal mass that frequently extends into the subcutis. The epidermis is infrequently involved, and the overlying skin is rarely ulcerated.
        </p>
        <p>
         The tumor is composed of strands or nests of monotonously uniform, round, blue cells, containing large basophilic nuclei with powdery dispersed chromatin and inconspicuous nucleoli, and minimal cytoplasm [
         <a href="#rid81">
          81
         </a>
         ]. Other features may include single-cell necrosis, frequent mitoses, lymphovascular invasion, perineural invasion, and epidermal involvement via pagetoid spread. Ultrastructurally, MCC tumor cells, like normal Merkel cells, contain paranuclear electron-dense neurosecretory granules (dense core granules), 10 mm filaments, and desmosomes [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         There are three main histologic patterns, which have not been demonstrated to have prognostic or therapeutic implications but may be helpful in differentiating MCC from other entities  (
         <a class="graphic graphic_picture graphicRef76388" href="/z/d/graphic/76388.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid81">
          81
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intermediate type
         </strong>
         – This variant, which is the most common, shows large, solid nodules made of diffuse sheets of basophilic cells with the characteristic round to oval nucleus, powdery chromatin, and inconspicuous nucleoli.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Small cell type
         </strong>
         – The small cell variant has small, round cells with scant cytoplasm, oval hyperchromatic nuclei, and prominent nucleoli. The tumor cells form a solid sheet or clusters, often with crush artifact and nuclear molding.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trabecular type
         </strong>
         – This variant, which is the least common, has round to polygonal cells with abundant cytoplasm; round, centrally located vesicular nuclei; and inconspicuous nucleoli arranged in an organoid, trabecular, or ribbon-like arrangement.
        </p>
        <p>
        </p>
        <p>
         In rare cases, MCC may exhibit squamous, eccrine, glandular, and melanocytic differentiation [
         <a href="#rid83">
          83,84
         </a>
         ]. The occurrence of focal areas of squamous or sarcomatous differentiation in MCC has been documented in several patients [
         <a href="#rid85">
          85,86
         </a>
         ]. The histogenesis and pathogenesis of these tumors are incompletely understood. They are Merkel cell polyomavirus (MCPyV) negative and have high frequency of retinoblastoma (
         <em>
          RB1
         </em>
         ) and
         <em>
          TP53
         </em>
         mutations [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H25265167">
         <span class="h2">
          Immunohistochemistry
         </span>
         <span class="headingEndMark">
          —
         </span>
         On immunohistochemistry, the Merkel cells show features of both epithelial and neuroendocrine cells [
         <a href="#rid82">
          82
         </a>
         ]. They express epithelial markers, such as AE1/AE3, CAM 5.2, pan-cytokeratin, epithelial membrane antigen, and Ber-EP4, and may stain for various neuroendocrine markers, including chromogranin, synaptophysin, calcitonin, vasoactive intestinal peptide, and somatostatin receptor [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Immunoreactivity for low molecular weight cytokeratins (eg, CK20, CK5/6) distinguishes MCC from other undifferentiated tumors  (
         <a class="graphic graphic_table graphicRef54954" href="/z/d/graphic/54954.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid88">
          88
         </a>
         ]. MCC stains positively for low molecular weight CK20, which is a fairly specific and sensitive marker for MCC, with a characteristic paranuclear dot-like positivity  (
         <a class="graphic graphic_picture graphicRef80961" href="/z/d/graphic/80961.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
         MCPyV large tumor (LT) antigen expression can be detected by using the commercially available mouse monoclonal antibody CM2B4  (
         <a class="graphic graphic_picture graphicRef61586" href="/z/d/graphic/61586.html" rel="external">
          picture 1
         </a>
         ). The LT antigen expression is highly correlated with the viral load (amount of MCPyV DNA) measured by real-time polymerase chain reaction [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H62522586">
         <span class="h2">
          Cytogenetic and molecular analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple chromosome abnormalities, including gains, losses, and rearrangements, have been detected in MCC. However, the relationship of these genetic changes to pathogenesis, natural history, and therapeutic outcomes is unclear.
        </p>
        <p>
         The chromosomes most frequently affected are 1, 5, 6, 8, and 13 [
         <a href="#rid42">
          42,89-91
         </a>
         ]. The pattern of chromosome gains and losses is similar to those seen in small cell cancer of the lung (SCLC) [
         <a href="#rid90">
          90
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4628.html" rel="external">
          "Pathobiology and staging of small cell carcinoma of the lung"
         </a>
         ). Structural abnormalities involving chromosome 1p have been noted in up to 40 percent of examined cases [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Somatic mutations in tumor suppressor genes, including
         <em>
          RB1
         </em>
         and
         <em>
          TP53
         </em>
         , have been documented in subsets of MCCs. Mutations in
         <em>
          TP53
         </em>
         have been found in 0 to 28 percent of MCCs, the majority of which represent single nucleotide polymorphisms or silent mutations of unknown clinical significance [
         <a href="#rid42">
          42
         </a>
         ].
         <em>
          RB1
         </em>
         -inactivating mutations occur in nearly all MCPyV-negative MCCs.
        </p>
        <p>
         Other molecular alterations found with varying frequency in MCC include mutations in genes involved in the tyrosine kinase signaling (
         <em>
          PIK3CA
         </em>
         ,
         <em>
          KIT
         </em>
         , and
         <em>
          PDGFR
         </em>
         ) and microRNA expression [
         <a href="#rid93">
          93,94
         </a>
         ]. Distinct expression profiles of microRNA (noncoding RNA sequences that silence translation of complementary messenger RNA transcripts) have been found in MCPyV-positive and -negative tumors, suggesting distinct molecular mechanisms in tumor development and progression based upon MCPyV status [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H65922483">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinically, Merkel cell carcinoma (MCC) may closely mimic many benign and malignant lesions occurring on sun-exposed skin, such as basal cell carcinoma, squamous cell carcinoma, keratoacanthoma, amelanotic melanoma, pyogenic granuloma, lipoma, and adnexal tumors. Histology can clarify the diagnosis in most cases. However, on conventional light microscopy, MCC is difficult to distinguish from other poorly differentiated cutaneous and noncutaneous "small, blue cell tumors," including [
         <a href="#rid96">
          96,97
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Small cell carcinoma of the lung
         </strong>
         – In contrast to MCC, cutaneous metastases of small cell carcinoma of the lung do not stain with CK20 but are positive for CK7, neuron-specific enolase, and thyroid transcription factor-1  (
         <a class="graphic graphic_table graphicRef54954" href="/z/d/graphic/54954.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid88">
          88,98
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4628.html" rel="external">
          "Pathobiology and staging of small cell carcinoma of the lung", section on 'Pathology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Small cell melanoma
         </strong>
         – Melanoma with small cell phenotype is a rare variant of melanoma that resembles MCC [
         <a href="#rid99">
          99,100
         </a>
         ]. Positive staining for HMB-45, Melan-A, and S-100 protein confirms the diagnosis of melanoma. (See
         <a class="medical medical_review" href="/z/d/html/4843.html" rel="external">
          "Pathologic characteristics of melanoma", section on 'Rare variants'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In such cases, immunohistochemistry is required for a definitive diagnosis  (
         <a class="graphic graphic_table graphicRef54954" href="/z/d/graphic/54954.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid82">
          82,101,102
         </a>
         ]. (See
         <a class="local">
          'Immunohistochemistry'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2879035601">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/15500.html" rel="external">
          "Patient education: Non-melanoma skin cancer (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology and pathogenesis
         </strong>
         – Merkel cell carcinoma (MCC) is a rare, cutaneous malignancy with a high propensity for local recurrence and distant metastases. It predominantly affects older individuals with light skin types. Multiple factors appear to contribute to the etiology of MCC, including the Merkel cell polyomavirus (MCPyV), ultraviolet (UV) radiation exposure, and immunosuppression. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Patients with MCC typically present with a rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule commonly located in the sun-exposed area  (
         <a class="graphic graphic_picture graphicRef70535 graphicRef50573 graphicRef52988" href="/z/d/graphic/70535.html" rel="external">
          picture 2A-C
         </a>
         ). (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of MCC requires a high index of suspicion, as it is often clinically misdiagnosed as a benign lesion (eg, cyst, lipoma, pyogenic granuloma). Clinical warning signs that should prompt a biopsy are summarized in the acronym AEIOU (
         <strong>
          a
         </strong>
         symptomatic lesion,
         <strong>
          e
         </strong>
         xpanding rapidly,
         <strong>
          i
         </strong>
         mmunosuppression, age
         <strong>
          o
         </strong>
         lder than 50 years, lesion on
         <strong>
          U
         </strong>
         V-exposed skin). The definitive diagnosis is made by histologic examination of a biopsy specimen and generally requires immunohistochemistry as well as routine staining to distinguish MCC from other poorly differentiated tumors  (
         <a class="graphic graphic_table graphicRef54954" href="/z/d/graphic/54954.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Staging and management
         </strong>
         – The staging and management of patients with MCC are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7609.html" rel="external">
          "Staging, treatment, and surveillance of locoregional Merkel cell carcinoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139691.html" rel="external">
          "Treatment of recurrent and metastatic Merkel cell carcinoma"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tothill R, Estall V, Rischin D. Merkel cell carcinoma: emerging biology, current approaches, and future directions. Am Soc Clin Oncol Educ Book 2015; :e519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol 2018; 78:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaar O, Gillstedt M, Lindelöf B, et al. Merkel cell carcinoma incidence is increasing in Sweden. J Eur Acad Dermatol Venereol 2016; 30:1708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer 2011; 47:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fondain M, Dereure O, Uhry Z, et al. Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey. J Eur Acad Dermatol Venereol 2018; 32:1292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Youlden DR, Soyer HP, Youl PH, et al. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol 2014; 150:864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson JP, Liang ES, Martin RC. Epidemiology of Merkel cell carcinoma in New Zealand: a population-based study. Br J Dermatol 2015; 173:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girschik J, Thorn K, Beer TW, et al. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol 2011; 165:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stang A, Becker JC, Nghiem P, Ferlay J. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment. Eur J Cancer 2018; 94:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010; 37:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clarke CA, Robbins HA, Tatalovich Z, et al. Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst 2015; 107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tadmor T, Aviv A, Polliack A. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011; 22:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bajetta E, Platania M, Catena L, et al. Merkel cell carcinoma after liver transplantation: a case report. Tumori 2007; 93:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bensaleh H, Perney P, Dereure O, et al. Merkel cell carcinoma in a liver transplant patient. Am J Clin Dermatol 2007; 8:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koljonen V, Kukko H, Tukiainen E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24:3231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manganoni MA, Farisoglio C, Tucci G, et al. Merkel cell carcinoma and HIV infection: a case report and review of the literature. AIDS Patient Care STDS 2007; 21:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard RA, Dores GM, Curtis RE, et al. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010; 102:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koljonen V, Kukko H, Pukkala E, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009; 101:1444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ratner D, Nelson BR, Brown MD, Johnson TM. Merkel cell carcinoma. J Am Acad Dermatol 1993; 29:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilling T, Moll I. Which are the cells of origin in merkel cell carcinoma? J Skin Cancer 2012; 2012:680410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sunshine JC, Jahchan NS, Sage J, Choi J. Are there multiple cells of origin of Merkel cell carcinoma? Oncogene 2018; 37:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nirenberg A, Steinman H, Dixon J, Dixon A. Merkel cell carcinoma update: the case for two tumours. J Eur Acad Dermatol Venereol 2020; 34:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kervarrec T, Appenzeller S, Samimi M, et al. Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation. J Invest Dermatol 2022; 142:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kassem A, Schöpflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008; 68:5009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharp CP, Norja P, Anthony I, et al. Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis 2009; 199:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leroux-Kozal V, Lévêque N, Brodard V, et al. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Hum Pathol 2015; 46:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santos-Juanes J, Fernández-Vega I, Fuentes N, et al. Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis. Br J Dermatol 2015; 173:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martel-Jantin C, Filippone C, Tortevoye P, et al. Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol 2014; 52:1687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viscidi RP, Rollison DE, Sondak VK, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011; 18:1737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martel-Jantin C, Pedergnana V, Nicol JT, et al. Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol 2013; 58:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen T, Hedman L, Mattila PS, et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sastre-Garau X, Peter M, Avril MF, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 2009; 218:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Church CD, Nghiem P. How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model. J Invest Dermatol 2015; 135:1221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeCaprio JA, Garcea RL. A cornucopia of human polyomaviruses. Nat Rev Microbiol 2013; 11:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erstad DJ, Jr JC. Mutational analysis of merkel cell carcinoma. Cancers (Basel) 2014; 6:2116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foulongne V, Dereure O, Kluger N, et al. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010; 162:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kassem A, Technau K, Kurz AK, et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009; 125:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rollison DE, Giuliano AR, Messina JL, et al. Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2012; 21:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murakami M, Imajoh M, Ikawa T, et al. Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma. J Clin Virol 2011; 50:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dworkin AM, Tseng SY, Allain DC, et al. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009; 129:2868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trizuljak J, Srovnal J, Plevová K, et al. Analysis of prognostic significance of merkel cell polyomavirus in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2015; 15:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Du-Thanh A, Dereure O, Guillot B, Foulongne V. Merkel cell polyomavirus: its putative involvement in a particular subset of cutaneous lymphoma with possibly unfavorable outcome. J Clin Virol 2014; 61:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reisinger DM, Shiffer JD, Cognetta AB Jr, et al. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J Am Acad Dermatol 2010; 63:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhan FQ, Packianathan VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J Natl Compr Canc Netw 2009; 7:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339:1247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000; 82:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popp S, Waltering S, Herbst C, et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002; 99:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harms PW, Vats P, Verhaegen ME, et al. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Res 2015; 75:3720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goh G, Walradt T, Markarov V, et al. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 2016; 7:3403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dabner M, McClure RJ, Harvey NT, et al. Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome. Pathology 2014; 46:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perrett CM, Walker SL, O'Donovan P, et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol 2008; 159:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309:1871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han W, Soltani K, Ming M, He YY. Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila) 2012; 5:1155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han W, Ming M, He TC, He YY. Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem 2010; 285:11369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ming M, Zhao B, Qiang L, He YY. Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response. Photochem Photobiol 2015; 91:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cimino PJ, Robirds DH, Tripp SR, et al. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma. Mod Pathol 2014; 27:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harms PW, Patel RM, Verhaegen ME, et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 2013; 133:936.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg ES, Chong KK, Huynh KT, et al. Epigenetic biomarkers in skin cancer. Cancer Lett 2014; 342:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veija T, Sahi H, Koljonen V, et al. miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma. Virchows Arch 2015; 466:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sihto H, Kukko H, Koljonen V, et al. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 2011; 17:4806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higaki-Mori H, Kuwamoto S, Iwasaki T, et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 2012; 43:2282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harms KL, Healy MA, Nghiem P, et al. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Ann Surg Oncol 2016; 23:3564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haymerle G, Fochtmann A, Kunstfeld R, et al. Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience. Eur Arch Otorhinolaryngol 2015; 272:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asgari MM, Sokil MM, Warton EM, et al. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol 2014; 150:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deneve JL, Messina JL, Marzban SS, et al. Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol 2012; 19:2360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandeven N, Lewis CW, Makarov V, et al. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival. Clin Cancer Res 2018; 24:963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu MA, Nguyen J, Driver JA. Influence of age and marital status on stage at diagnosis and survival of patients with Merkel cell carcinoma: A Surveillance, Epidemiology, and End Results registry-based cohort study. J Am Acad Dermatol 2018; 79:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalilian C, Chamberlain AJ, Haskett M, et al. Clinical and dermoscopic characteristics of Merkel cell carcinoma. Br J Dermatol 2013; 169:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harting MS, Ludgate MW, Fullen DR, et al. Dermatoscopic vascular patterns in cutaneous Merkel cell carcinoma. J Am Acad Dermatol 2012; 66:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalle S, Parmentier L, Moscarella E, et al. Dermoscopy of Merkel cell carcinoma. Dermatology 2012; 224:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scalvenzi M, Palmisano F, Ilardi G, et al. Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand. J Dermatol Case Rep 2013; 7:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong HH, Wang J. Merkel cell carcinoma. Arch Pathol Lab Med 2010; 134:1711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warner TF, Uno H, Hafez GR, et al. Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature. Cancer 1983; 52:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin B, Poblet E, Rios JJ, et al. Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus. Histopathology 2013; 62:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saeb-Lima M, Montante-Montes de Oca D, Albores-Saavedra J. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases. Ann Diagn Pathol 2008; 12:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narisawa Y, Koba S, Inoue T, Nagase K. Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases. J Dermatol 2015; 42:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pulitzer MP, Brannon AR, Berger MF, et al. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol 2015; 28:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gardair C, Samimi M, Touzé A, et al. Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity. Neuroendocrinology 2015; 101:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Gele M, Speleman F, Vandesompele J, et al. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58:1503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sozzi G, Bertoglio MG, Pilotti S, et al. Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet Cytogenet 1988; 30:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Gele M, Van Roy N, Ronan SG, et al. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 1998; 23:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swick BL, Srikantha R, Messingham KN. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma. J Cutan Pathol 2013; 40:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iwasaki T, Matsushita M, Nonaka D, et al. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas. Hum Pathol 2015; 46:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xie H, Lee L, Caramuta S, et al. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma. J Invest Dermatol 2014; 134:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daoud MA, Mete O, Al Habeeb A, Ghazarian D. Neuroendocrine carcinoma of the skin--an updated review. Semin Diagn Pathol 2013; 30:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol 2009; 16:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leech SN, Kolar AJ, Barrett PD, et al. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song HS, Kim YC. Small cell melanoma. Ann Dermatol 2014; 26:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           House NS, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J Am Acad Dermatol 1994; 31:839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 1985; 9:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyer-Pannwitt U, Kummerfeldt K, Boubaris P, Caselitz J. [Merkel cell tumor or neuroendocrine skin carcinoma]. Langenbecks Arch Chir 1997; 382:349.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7623 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25993218" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Merkel cell carcinoma: emerging biology, current approaches, and future directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29102486" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27136306" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Merkel cell carcinoma incidence is increasing in Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21144740" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29341266" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24943712" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25801524" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology of Merkel cell carcinoma in New Zealand: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21711338" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29533867" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19638070" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18280333" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25575645" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Risk of merkel cell carcinoma after solid organ transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10609948" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Merkel's cell carcinoma in organ recipients: report of 41 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20587511" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17679476" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Merkel cell carcinoma after liver transplantation: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17645379" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Merkel cell carcinoma in a liver transplant patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19586970" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incidence of Merkel cell carcinoma in renal transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11853800" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Merkel cell carcinoma and HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17651025" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Merkel cell carcinoma and HIV infection: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16896047" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Merkel cell carcinoma and multiple primary cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20424236" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19755994" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8335732" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23304516" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Which are the cells of origin in merkel cell carcinoma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29321666" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Are there multiple cells of origin of Merkel cell carcinoma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31855292" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Merkel cell carcinoma update: the case for two tumours.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34480892" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18202256" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Clonal integration of a polyomavirus in human Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18593898" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19090778" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19776382" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25623078" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25919492" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24523477" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542254" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21880855" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23829968" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21094082" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Serological evidence of Merkel cell polyomavirus primary infections in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19291712" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25882464" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23474680" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : A cornucopia of human polyomaviruses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25329450" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Mutational analysis of merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19678822" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19384948" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22016472" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20965777" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19554019" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25758600" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Analysis of prognostic significance of merkel cell polyomavirus in chronic lymphocytic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25049207" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Merkel cell polyomavirus: its putative involvement in a particular subset of cutaneous lymphoma with possibly unfavorable outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20584559" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10067813" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Merkel cell carcinoma and melanoma: etiological similarities and differences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14576661" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Epidemiology of primary Merkel cell carcinoma in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19401065" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Merkel cell carcinoma: a review of current advances.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9786759" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10732753" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11992403" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26238782" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26655088" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24614722" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18489587" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Azathioprine treatment photosensitizes human skin to ultraviolet A radiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16166520" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Azathioprine and UVA light generate mutagenic oxidative DNA damage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22846842" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20154081" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25039758" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24406863" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23223137" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22289720" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Epigenetic biomarkers in skin cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25491743" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21642382" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22795182" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27198511" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24633244" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24807619" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22271206" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Merkel cell carcinoma of unknown primary origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29246939" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29864470" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Influence of age and marital status on stage at diagnosis and survival of patients with Merkel cell carcinoma: A Surveillance, Epidemiology, and End Results registry-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23574613" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Clinical and dermoscopic characteristics of Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21978573" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Dermatoscopic vascular patterns in cutaneous Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22487601" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Dermoscopy of Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23580909" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21043828" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6344978" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23530585" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18995205" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25720654" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26022453" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25765179" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9042291" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8504402" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9537255" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3422041" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9713999" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23621836" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25466966" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23962809" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24144292" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Neuroendocrine carcinoma of the skin--an updated review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19395876" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Merkel cell carcinoma: review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11533085" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24966654" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Small cell melanoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7525666" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Malignant melanoma with clinical and histologic features of Merkel cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2579594" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9498208" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : [Merkel cell tumor or neuroendocrine skin carcinoma].
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
